Rezultati pretraživanja
  1. prije 10 sati

    We are united in the fight against Cancer. Be Aware. Live Informed!

    3 korisnika označavaju da im se sviđa
  2. prije 21 sat

    Which genetic tests are best for ? Watch this short video with expert, Alex Rolland, to find out.

    2 korisnika označavaju da im se sviđa
  3. prije 21 sat

    Exciting news about our sponsor : , one of the largest oncology practices in the nation, using to ensure every patient has access to . Lori Brisbin-Ferraro, VP of Precision Medicine explains.

    WATCH: Utility of Trapelo to Increase Molecular Testing Rates
    1 reply 2 proslijeđena tweeta 2 korisnika označavaju da im se sviđa
  4. 3. velj

    Deep Lens finds more patients - VIPER is strikingly powerful, with the ability to identify and recruit patients who would otherwise have gone undetected.

    1 korisnik označava da mu se sviđa
  5. 2. velj

    Do you have questions about ? Watch an all new this Thurs. Feb. 6th at 1pm PST! This week's spotlight is on : risks, symptoms, and new treatments. Visit our Facebook page to see it live!

    3 korisnika označavaju da im se sviđa
  6. 2. velj

    Exciting news for women with who've stopped responding to treatment. New has identified emerging mutations in the gene. Contact us to learn how you can benefit:

    1 proslijeđeni tweet 5 korisnika označava da im se sviđa
  7. 1. velj

    What is and how can it help you? Here's a short introduction, with cancer expert Alex Rolland:

    1 proslijeđeni tweet
  8. 31. sij

    How Immunotherapy Helped Damian With Colon Cancer

    1 korisnik označava da mu se sviđa
  9. 31. sij

    Out now: our preprint on large-scale RNA-seq mutation calling in 3217 primary breast tumors from the population-based study.

    1 reply 2 proslijeđena tweeta 1 korisnik označava da mu se sviđa
    Prikaži ovu nit
    Prikaži ovu nit
  10. 30. sij
    Odgovor korisnicima

    taking over

  11. 30. sij

    Impressive : shares surge 88%

    2 korisnika označavaju da im se sviđa
    Prikaži ovu nit
    Prikaži ovu nit
  12. 30. sij

    and the History of by Deborah B. Doroshow & James H. Doroshow

    2 proslijeđena tweeta 2 korisnika označavaju da im se sviđa
  13. 30. sij

    Why you need to ask for a on your and treatment plan:

    1 proslijeđeni tweet 2 korisnika označavaju da im se sviđa
  14. 30. sij

    What's the most crucial element to getting an effective plan? Find out!

    1 proslijeđeni tweet 4 korisnika označavaju da im se sviđa
  15. 30. sij

    The FDA just granted Priority Review to selpercatinib for the treatment of RET fusion+

    1 proslijeđeni tweet
  16. 30. sij

  17. 30. sij

    RT : Microscaled proteogenomic methods for precision oncology

    7 proslijeđenih tweetova 10 korisnika označava da im se sviđa
  18. 29. sij

    Join us for a new episode of - a Live Video Show where YOU can ask a expert anything you want! This week's spotlight is on . Visit 's Facebook pg at 1pm PST on Thurs. Jan. 30th:

    1 korisnik označava da mu se sviđa
  19. 29. sij

    The Oncidium foundation will be at the EANM Focus Meeting tomorrow! An interesting overview of the latest developments in neuroendocrine tumours and futur directions with . Let's meet !

    2 proslijeđena tweeta 5 korisnika označava da im se sviđa
  20. 28. sij

    Identifying responders remains a key challenge in . Our paper in explores the impact of filtering out the signal from leukocytes in to better predict recurrence in .

    1 reply 12 proslijeđenih tweetova 40 korisnika označava da im se sviđa

Nema rezultata.

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.